Updates are available Correction dated 2018-04-10

Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in Japan

Crossref DOI link: https://doi.org/10.1007/s40272-017-0264-y

Published Online: 2017-09-11

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy